世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ニコチンガムの世界市場 2021-2025


Global Nicotine Gum Market 2021-2025

ニコチンガムの世界市場 2021-2025 Technavioはニコチンガム市場を監視しており、2021年から2025年の間に10億1000万ドルの成長が見込まれ、予測期間中にCAGR 4.43%で減速します。当レポートでは、ニコチンガム... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2022年1月17日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

ニコチンガムの世界市場 2021-2025
Technavioはニコチンガム市場を監視しており、2021年から2025年の間に10億1000万ドルの成長が見込まれ、予測期間中にCAGR 4.43%で減速します。当レポートでは、ニコチンガム市場の全体分析、市場規模・予測、トレンド、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、禁煙しようとする人の増加や、タバコの害に関する意識の高まりによって牽引されています。また、禁煙を試みる人々の増加は、市場の成長をも押し上げると予測されます。
ニコチンガム市場の分析には、製品セグメントと地理的状況も含まれます。
Technavioのニコチンガム市場は、以下のように区分されています。
製品別
- 2-mgニコチン
- 4-mgニコチン
地域別状況
- 北アメリカ
- 欧州
- APAC
- 南米
- MEA
本調査では、今後数年間のニコチンガム市場の成長を促進する主要な理由の一つとして、禁煙治療への登録が増加していることを挙げています。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な図を提示します。ニコチンガム市場に関する弊社のレポートは、以下の分野を対象としています。
- ニコチンガム市場のサイジング
- ニコチンガム市場予測
- ニコチンガム市場の産業分析
Technavioの強固なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、British American Tobacco Plc、Cambrex Corp、Cipla Inc、GlaxoSmithKline Plc、Glenmark Pharmaceuticals Ltd、ITC Ltd、Johnson and Johnson Inc、Lil Drug Store Products Inc、Major Pharmaceuticals Inc、およびWalgreen Coなど、いくつかの主要ニコチンガス市場ベンダーに関する詳細分析を提供しています。また、ニコチンガム市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/nicotine-gum-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータを調査、合成、総括する方法で、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る


目次

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2021
o Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o 2-mg nicotine - Market size and forecast 2020-2025
o 4-mg nicotine - Market size and forecast 2020-2025
o Market opportunity by Product
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2020-2025
o Europe - Market size and forecast 2020-2025
o APAC - Market size and forecast 2020-2025
o South America - Market size and forecast 2020-2025
o MEA - Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
• Drivers, Challenges, and Trends
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Landscape disruption
o Competitive scenario
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o British American Tobacco Plc
o Cambrex Corp.
o Cipla Inc.
o GlaxoSmithKline Plc
o Glenmark Pharmaceuticals Ltd.
o ITC Ltd.
o Johnson and Johnson Inc.
o Lil Drug Store Products Inc.
o Major Pharmaceuticals Inc.
o Walgreen Co.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research Methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2020 - 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 - 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2020
• 21: Product - Market share 2020-2025 (%)
• 22: Comparison by Product
• 23: 2-mg nicotine - Market size and forecast 2020-2025 ($ million)
• 24: 2-mg nicotine - Year-over-year growth 2020-2025 (%)
• 25: 4-mg nicotine - Market size and forecast 2020-2025 ($ million)
• 26: 4-mg nicotine - Year-over-year growth 2020-2025 (%)
• 27: Market opportunity by Product
• 28: Customer landscape
• 29: Market share By Geographical Landscape 2020-2025 (%)
• 30: Geographic comparison
• 31: North America - Market size and forecast 2020-2025 ($ million)
• 32: North America - Year-over-year growth 2020-2025 (%)
• 33: Europe - Market size and forecast 2020-2025 ($ million)
• 34: Europe - Year-over-year growth 2020-2025 (%)
• 35: APAC - Market size and forecast 2020-2025 ($ million)
• 36: APAC - Year-over-year growth 2020-2025 (%)
• 37: South America - Market size and forecast 2020-2025 ($ million)
• 38: South America - Year-over-year growth 2020-2025 (%)
• 39: MEA - Market size and forecast 2020-2025 ($ million)
• 40: MEA - Year-over-year growth 2020-2025 (%)
• 41: Key leading countries
• 42: Market opportunity By Geographical Landscape ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: British American Tobacco Plc - Overview
• 50: British American Tobacco Plc - Business segments
• 51: British American Tobacco Plc - Key offerings
• 52: British American Tobacco Plc - Key customers
• 53: British American Tobacco Plc - Segment focus
• 54: Cambrex Corp. - Overview
• 55: Cambrex Corp. - Product and service
• 56: Cambrex Corp. - Key offerings
• 57: Cambrex Corp. - Key customers
• 58: Cambrex Corp. - Segment focus
• 59: Cipla Inc. - Overview
• 60: Cipla Inc. - Business segments
• 61: Cipla Inc. - Key offerings
• 62: Cipla Inc. - Key customers
• 63: Cipla Inc. - Segment focus
• 64: GlaxoSmithKline Plc - Overview
• 65: GlaxoSmithKline Plc - Business segments
• 66: GlaxoSmithKline Plc - Key offerings
• 67: GlaxoSmithKline Plc - Key customers
• 68: GlaxoSmithKline Plc - Segment focus
• 69: Glenmark Pharmaceuticals Ltd. - Overview
• 70: Glenmark Pharmaceuticals Ltd. - Business segments
• 71: Glenmark Pharmaceuticals Ltd. - Key offerings
• 72: Glenmark Pharmaceuticals Ltd. - Key customers
• 73: Glenmark Pharmaceuticals Ltd. - Segment focus
• 74: ITC Ltd. - Overview
• 75: ITC Ltd. - Business segments
• 76: ITC Ltd. - Key offerings
• 77: ITC Ltd. - Key customers
• 78: ITC Ltd. - Segment focus
• 79: Johnson and Johnson Inc. - Overview
• 80: Johnson and Johnson Inc. - Business segments
• 81: Johnson and Johnson Inc. - Key offerings
• 82: Johnson and Johnson Inc. - Key customers
• 83: Johnson and Johnson Inc. - Segment focus
• 84: Lil Drug Store Products Inc. - Overview
• 85: Lil Drug Store Products Inc. - Product and service
• 86: Lil Drug Store Products Inc. - Key offerings
• 87: Lil Drug Store Products Inc. - Key customers
• 88: Lil Drug Store Products Inc. - Segment focus
• 89: Major Pharmaceuticals Inc. - Overview
• 90: Major Pharmaceuticals Inc. - Product and service
• 91: Major Pharmaceuticals Inc. - Key offerings
• 92: Major Pharmaceuticals Inc. - Key customers
• 93: Major Pharmaceuticals Inc. - Segment focus
• 94: Walgreen Co. - Overview
• 95: Walgreen Co. - Product and service
• 96: Walgreen Co. - Key offerings
• 97: Walgreen Co. - Key customers
• 98: Walgreen Co. - Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Nicotine Gum Market 2021-2025
Technavio has been monitoring the nicotine gum market and it is poised to grow by $ 1.01 bn during 2021-2025, decelerating at a CAGR of 4.43% during the forecast period. Our report on the nicotine gum market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing number of people trying to quit smoking and increasing awareness about the harmful effects of cigarette smoking. In addition, the increasing number of people trying to quit smoking is anticipated to boost the growth of the market as well.
The nicotine gum market analysis includes the product segment and geographic landscape.
Technavio's nicotine gum market is segmented as below:
By Product
• 2-mg nicotine
• 4-mg nicotine
By Geographical Landscape
• North America
• Europe
• APAC
• South America
• MEA
This study identifies the growing enrolment in smoking cessation therapiesas one of the prime reasons driving the nicotine gum market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on nicotine gum market covers the following areas:
• Nicotine gum market sizing
• Nicotine gum market forecast
• Nicotine gum market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading nicotine gum market vendors that include British American Tobacco Plc, Cambrex Corp., Cipla Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., ITC Ltd., Johnson and Johnson Inc., Lil Drug Store Products Inc., Major Pharmaceuticals Inc., and Walgreen Co. Also, the nicotine gum market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/nicotine-gum-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2021
o Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o 2-mg nicotine - Market size and forecast 2020-2025
o 4-mg nicotine - Market size and forecast 2020-2025
o Market opportunity by Product
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2020-2025
o Europe - Market size and forecast 2020-2025
o APAC - Market size and forecast 2020-2025
o South America - Market size and forecast 2020-2025
o MEA - Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
• Drivers, Challenges, and Trends
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Landscape disruption
o Competitive scenario
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o British American Tobacco Plc
o Cambrex Corp.
o Cipla Inc.
o GlaxoSmithKline Plc
o Glenmark Pharmaceuticals Ltd.
o ITC Ltd.
o Johnson and Johnson Inc.
o Lil Drug Store Products Inc.
o Major Pharmaceuticals Inc.
o Walgreen Co.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research Methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2020 - 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 - 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2020
• 21: Product - Market share 2020-2025 (%)
• 22: Comparison by Product
• 23: 2-mg nicotine - Market size and forecast 2020-2025 ($ million)
• 24: 2-mg nicotine - Year-over-year growth 2020-2025 (%)
• 25: 4-mg nicotine - Market size and forecast 2020-2025 ($ million)
• 26: 4-mg nicotine - Year-over-year growth 2020-2025 (%)
• 27: Market opportunity by Product
• 28: Customer landscape
• 29: Market share By Geographical Landscape 2020-2025 (%)
• 30: Geographic comparison
• 31: North America - Market size and forecast 2020-2025 ($ million)
• 32: North America - Year-over-year growth 2020-2025 (%)
• 33: Europe - Market size and forecast 2020-2025 ($ million)
• 34: Europe - Year-over-year growth 2020-2025 (%)
• 35: APAC - Market size and forecast 2020-2025 ($ million)
• 36: APAC - Year-over-year growth 2020-2025 (%)
• 37: South America - Market size and forecast 2020-2025 ($ million)
• 38: South America - Year-over-year growth 2020-2025 (%)
• 39: MEA - Market size and forecast 2020-2025 ($ million)
• 40: MEA - Year-over-year growth 2020-2025 (%)
• 41: Key leading countries
• 42: Market opportunity By Geographical Landscape ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: British American Tobacco Plc - Overview
• 50: British American Tobacco Plc - Business segments
• 51: British American Tobacco Plc - Key offerings
• 52: British American Tobacco Plc - Key customers
• 53: British American Tobacco Plc - Segment focus
• 54: Cambrex Corp. - Overview
• 55: Cambrex Corp. - Product and service
• 56: Cambrex Corp. - Key offerings
• 57: Cambrex Corp. - Key customers
• 58: Cambrex Corp. - Segment focus
• 59: Cipla Inc. - Overview
• 60: Cipla Inc. - Business segments
• 61: Cipla Inc. - Key offerings
• 62: Cipla Inc. - Key customers
• 63: Cipla Inc. - Segment focus
• 64: GlaxoSmithKline Plc - Overview
• 65: GlaxoSmithKline Plc - Business segments
• 66: GlaxoSmithKline Plc - Key offerings
• 67: GlaxoSmithKline Plc - Key customers
• 68: GlaxoSmithKline Plc - Segment focus
• 69: Glenmark Pharmaceuticals Ltd. - Overview
• 70: Glenmark Pharmaceuticals Ltd. - Business segments
• 71: Glenmark Pharmaceuticals Ltd. - Key offerings
• 72: Glenmark Pharmaceuticals Ltd. - Key customers
• 73: Glenmark Pharmaceuticals Ltd. - Segment focus
• 74: ITC Ltd. - Overview
• 75: ITC Ltd. - Business segments
• 76: ITC Ltd. - Key offerings
• 77: ITC Ltd. - Key customers
• 78: ITC Ltd. - Segment focus
• 79: Johnson and Johnson Inc. - Overview
• 80: Johnson and Johnson Inc. - Business segments
• 81: Johnson and Johnson Inc. - Key offerings
• 82: Johnson and Johnson Inc. - Key customers
• 83: Johnson and Johnson Inc. - Segment focus
• 84: Lil Drug Store Products Inc. - Overview
• 85: Lil Drug Store Products Inc. - Product and service
• 86: Lil Drug Store Products Inc. - Key offerings
• 87: Lil Drug Store Products Inc. - Key customers
• 88: Lil Drug Store Products Inc. - Segment focus
• 89: Major Pharmaceuticals Inc. - Overview
• 90: Major Pharmaceuticals Inc. - Product and service
• 91: Major Pharmaceuticals Inc. - Key offerings
• 92: Major Pharmaceuticals Inc. - Key customers
• 93: Major Pharmaceuticals Inc. - Segment focus
• 94: Walgreen Co. - Overview
• 95: Walgreen Co. - Product and service
• 96: Walgreen Co. - Key offerings
• 97: Walgreen Co. - Key customers
• 98: Walgreen Co. - Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る